Impact of Antipsychotic Treatment on Nonfasting Triglycerides in the CATIE Schizophrenia Trial Phase 1

BACKGROUND: Recent literature documents a stronger association between nonfasting triglycerides (TG) and cardiovascular risk compared to fasting TG. Given concerns over antipsychotic effects on serum TG, this analysis explored changes in nonfasting TG in phase 1 of the CATIE Schizophrenia Trial. MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Meyer, Jonathan M., Davis, Vicki G., McEvoy, Joseph P., Goff, Donald C., Nasrallah, Henry A., Davis, Sonia M., Daumit, Gail L., Hsiao, John, Swartz, Marvin S., Stroup, T. Scott, Lieberman, Jeffrey A.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2583138/
https://ncbi.nlm.nih.gov/pubmed/18534821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2008.04.023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars